University Hospital Kralovske Vinohrady
Prague, Czechia
6 recruiting
Showing 1–6 of 6 trials
Recruiting
LA Function After PFA in Paroxysmal AF
Atrial Fibrillation (AF)
Charles University, Czech Republic50 enrolled1 locationNCT07439016
Recruiting
Phase 3
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Follicular Lymphoma ( FL)
Regeneron Pharmaceuticals822 enrolled190 locationsNCT06091254
Recruiting
Phase 3
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
Relapsed/Refractory Follicular LymphomaRelapsed/Refractory Marginal Zone Lymphoma (R/R MZL)
Regeneron Pharmaceuticals470 enrolled168 locationsNCT06149286
Recruiting
Left Atrial Posterior Wall and Mitral Isthmus PF Ablation in Non-Paroxysmal AF Patients
Atrial Fibrillation (AF)
Charles University, Czech Republic50 enrolled1 locationNCT06801392
Recruiting
Epidemiological Factors and Optimization of Conservative Approaches to Precancerous Lesions of Female Reproductive Organs
Cervical CancerRisk FactorsCervical Intraepithelial Neoplasia (CIN)+1 more
Nikola Janovska200 enrolled1 locationNCT06967740
Recruiting
Prognostic Significance of ctDNA in HL
Prognostic Cancer Model
Interni hematologicka klinika FNKV500 enrolled5 locationsNCT06263530